Hybrid event with virtual attendance options

Overview

Join this hybrid program in person or virtually. This course will provide an update on recent developments in the management of patients with advanced liver disease including recent improvements in the medical management of steatotic liver disease, alcohol use disorder and alcoholic liver disease, and hepatic complications of heart disease. In addition, updates on acute on chronic liver failure, evaluation of substance use disorders in patients with advanced liver disease, liver transplantation for patients with metastatic colorectal cancer and neuroendocrine tumors, use of marginal organs in liver transplantation, and the medical management of long-term liver transplant recipients will be provided.

Learning Objectives

At the conclusion of this activity, learners will be able to:

1. implement newer approaches to the diagnosis, staging, and treatment of patients with metabolic associated liver disease
2. use appropriate diagnostic tools and treatment strategies for patients with alcoholic liver disease
3. understand and recognize common hepatic manifestations of patients with congenital and acquired heart disease
4. understand current classification schemes and medical recommendations for patients with acute on chronic liver failure
5. implement how to evaluate and treat patients with substance use disorders with underlying liver disease
6. understand new data on the indications and outcomes with liver transplantation for patients with metastatic colorectal cancer and neuroendocrine tumors to the liver
7. understand what is considered a "marginal organ" for liver transplantation and how they fare in adult recipients
8. implement medications and treatments that are recommended for LT recipients with hyperlipidemia, cancer and metabolic bone disease

Target Audience

Specialties - Family Medicine, Gastroenterology, General Medicine, Hepatology, Internal Medicine, Primary Care, Surgery, Transplant Surgery

Professions - House Officer, Nurse, Nurse Practitioner, Other Healthcare Professional, Physician, Physician Assistant, Social Worker

Accreditation

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

AMA PRA Category 1
The University of Michigan Medical School designates this Live Activity for a maximum of 5.75 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Social Work
This course is approved by NASW-Michigan for 5.5 credits. (Approval number 020425-03).

Transplant Certification
The American Board for Transplant Certification (ABTC) has approved this educational offering for up to 5.75 Category 1 Continuing Education Points for Transplant Certification (CEPTCs). Approved CEPTC Provider Number 141-64.

For more information, click the REGISTER NOW button below